The described ultra low-power remote ECG monitoring system enables continuous monitoring for over 20 days on a small battery, potentially facilitating long-term arrhythmia screening.
Feasible low-power 3-lead wearable ECG with BLE shown; leaves open clinical validation for arrhythmia screening.
A complete system solution extracting signals from the patient chest with three leads including motion artifact removal in both analog and digital implementations are described. The resulting ECG signal is transferred via Bluetooth low energy to a mobile phone. Using deep sleep modes, the overall power consumption is less than 300 $μ$A and the device can operate for more than 20 days using a 150mAh battery. The screening software looks for suspicious traces such as those with missing pulses, tachycardia, bradycardia, etc. The mobile phone software also eliminates any remaining motion artifact. The traces are subsequently processed in detail in a cloud server and to a physicians dashboard for long-term monitoring.
No takes yet. Share an insight, caveat, or question.
Hadizadeh et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: